AIM ImmunoTech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-28.96	-19.45	-19.13	-14.4	-9.4	-9.83	-8.26	-7.5	-15.23	-17.45	Upgrade
Depreciation & Amortization	0.53	-0.42	0.78	0.73	0.79	0.88	0.95	1.12	0.94	0.67	Upgrade
Share-Based Compensation	0.24	0.95	1.57	1.04	0.85	0.93	0.57	0.41	0.18	0.33	Upgrade
Other Operating Activities	6.93	2.81	2.82	2.26	-1.31	-2.62	-1.2	-1.41	-1.95	2.5	Upgrade
Operating Cash Flow	-21.27	-16.11	-13.97	-10.37	-9.07	-10.64	-7.94	-7.38	-16.05	-13.96	Upgrade
Capital Expenditures	0.05	3.81	0.2	-0.02	-0.07	1	-0.07	-0.45	-0.49	-0.76	Upgrade
Change in Investments	-0.29	7.36	-0.24	-8.57	-5.78	-0.83	2.8	3.37	6.84	3.29	Upgrade
Other Investing Activities	-0.59	-0.19	-0.59	-0.57	-0.3	-0.08	-	-	-	-	Upgrade
Investing Cash Flow	-0.83	10.99	-0.63	-9.16	-6.15	0.09	2.73	2.92	6.35	2.53	Upgrade
Share Issuance / Repurchase	0.49	0.08	13.04	61.25	15.3	5.07	2.42	4.74	9.68	12.82	Upgrade
Debt Issued / Paid	0	0	-4.85	-4.69	1.08	4.48	1.8	-0	-0.02	-0.03	Upgrade
Other Financing Activities	-	-	-	-	-	-0.11	-	0.01	-	0	Upgrade
Financing Cash Flow	0.49	0.08	8.19	56.56	16.39	9.44	4.22	4.76	9.66	12.79	Upgrade
Net Cash Flow	-21.61	-5.04	-6.41	37.03	1.17	-1.11	-1	0.29	-0.04	1.35	Upgrade
Free Cash Flow	-21.22	-12.29	-13.76	-10.39	-9.14	-9.64	-8.01	-7.83	-16.54	-14.73	Upgrade
Free Cash Flow Margin	-10504.95%	-8719.15%	-10193.33%	-6374.23%	-6525.00%	-2626.98%	-1832.95%	-8515.22%	-12438.35%	-7475.13%	Upgrade
Free Cash Flow Per Share	-0.44	-0.26	-0.29	-0.33	-2.51	-9.60	-12.29	-15.80	-36.99	-41.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).